170 related articles for article (PubMed ID: 26355221)
1. Substrates of the human oligopeptide transporter hPEPT2.
Zhao D; Lu K
Biosci Trends; 2015 Aug; 9(4):207-13. PubMed ID: 26355221
[TBL] [Abstract][Full Text] [Related]
2. Biology of Peptide Transporter 2 in Mammals: New Insights into Its Function, Structure and Regulation.
Wang C; Chu C; Ji X; Luo G; Xu C; He H; Yao J; Wu J; Hu J; Jin Y
Cells; 2022 Sep; 11(18):. PubMed ID: 36139448
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H+/peptide transporter PEPT2.
Fujita T; Kishida T; Wada M; Okada N; Yamamoto A; Leibach FH; Ganapathy V
Brain Res; 2004 Jan; 997(1):52-61. PubMed ID: 14715149
[TBL] [Abstract][Full Text] [Related]
4. Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions.
Nielsen CU; Brodin B
Curr Drug Targets; 2003 Jul; 4(5):373-88. PubMed ID: 12816347
[TBL] [Abstract][Full Text] [Related]
5. Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
Brandsch M
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):887-905. PubMed ID: 19519280
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.
Terada T; Sawada K; Irie M; Saito H; Hashimoto Y; Inui K
Pflugers Arch; 2000 Sep; 440(5):679-84. PubMed ID: 11007306
[TBL] [Abstract][Full Text] [Related]
7. The renal type H+/peptide symporter PEPT2: structure-affinity relationships.
Biegel A; Knütter I; Hartrodt B; Gebauer S; Theis S; Luckner P; Kottra G; Rastetter M; Zebisch K; Thondorf I; Daniel H; Neubert K; Brandsch M
Amino Acids; 2006 Sep; 31(2):137-56. PubMed ID: 16868651
[TBL] [Abstract][Full Text] [Related]
8. Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein.
Groneberg DA; Döring F; Theis S; Nickolaus M; Fischer A; Daniel H
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1172-9. PubMed ID: 11934684
[TBL] [Abstract][Full Text] [Related]
9. H(+)/peptide transporter (PEPT2) is expressed in human epidermal keratinocytes and is involved in skin oligopeptide transport.
Kudo M; Katayoshi T; Kobayashi-Nakamura K; Akagawa M; Tsuji-Naito K
Biochem Biophys Res Commun; 2016 Jul; 475(4):335-41. PubMed ID: 27216463
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of the peptide transporter PEPT2 in primary cultures of human upper airway epithelium.
Bahadduri PM; D'Souza VM; Pinsonneault JK; Sadée W; Bao S; Knoell DL; Swaan PW
Am J Respir Cell Mol Biol; 2005 Apr; 32(4):319-25. PubMed ID: 15626774
[TBL] [Abstract][Full Text] [Related]
11. Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake.
Groneberg DA; Nickolaus M; Springer J; Döring F; Daniel H; Fischer A
Am J Pathol; 2001 Feb; 158(2):707-14. PubMed ID: 11159208
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of dipeptide and drug transport by the human renal H+/oligopeptide cotransporter hPEPT2.
Sala-Rabanal M; Loo DD; Hirayama BA; Wright EM
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1422-32. PubMed ID: 18367661
[TBL] [Abstract][Full Text] [Related]
13. Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.
Smith DE; Clémençon B; Hediger MA
Mol Aspects Med; 2013; 34(2-3):323-36. PubMed ID: 23506874
[TBL] [Abstract][Full Text] [Related]
14. Stoichiometry and kinetics of the high-affinity H+-coupled peptide transporter PepT2.
Chen XZ; Zhu T; Smith DE; Hediger MA
J Biol Chem; 1999 Jan; 274(5):2773-9. PubMed ID: 9915809
[TBL] [Abstract][Full Text] [Related]
15. A rapid in vitro screening for delivery of peptide-derived peptidase inhibitors as potential drug candidates via epithelial peptide transporters.
Foltz M; Meyer A; Theis S; Demuth HU; Daniel H
J Pharmacol Exp Ther; 2004 Aug; 310(2):695-702. PubMed ID: 15051798
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport.
Groneberg DA; Fischer A; Chung KF; Daniel H
Am J Respir Cell Mol Biol; 2004 Mar; 30(3):251-60. PubMed ID: 14969997
[TBL] [Abstract][Full Text] [Related]
17. The bioactive dipeptide anserine is transported by human proton-coupled peptide transporters.
Geissler S; Zwarg M; Knütter I; Markwardt F; Brandsch M
FEBS J; 2010 Feb; 277(3):790-5. PubMed ID: 20067523
[TBL] [Abstract][Full Text] [Related]
18. Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants.
Song F; Hu Y; Jiang H; Smith DE
Drug Metab Dispos; 2017 Feb; 45(2):130-136. PubMed ID: 27836942
[TBL] [Abstract][Full Text] [Related]
19. Defining minimal structural features in substrates of the H(+)/peptide cotransporter PEPT2 using novel amino acid and dipeptide derivatives.
Theis S; Hartrodt B; Kottra G; Neubert K; Daniel H
Mol Pharmacol; 2002 Jan; 61(1):214-21. PubMed ID: 11752223
[TBL] [Abstract][Full Text] [Related]
20. Construction, identification and application of HeLa cells stably transfected with human PEPT1 and PEPT2.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Kaku T; Liu K
Peptides; 2012 Apr; 34(2):395-403. PubMed ID: 22369721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
